Skip to main content
Clinical Trials/PACTR202310817339585
PACTR202310817339585
Not yet recruiting
未知

se of continuous glucose monitoring devices among people living with type 1 diabetes in South Africa: A three-arm pragmatic randomized study on the effectiveness, feasibility, acceptability, and cost.

Foundation for Innovative New Diagnostics0 sites246 target enrollmentJune 19, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Nutritional, Metabolic, Endocrine
Sponsor
Foundation for Innovative New Diagnostics
Enrollment
246
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 19, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Recipients of Care eligibility criteria:
  • People living with type 1 diabetes with current HbA1c levels \=10% / \>86mmol/mol (and for at least 2 measurements over 18 months) attending for diabetes care at the 3 sites.
  • Health care providers eligibility criteria:
  • Healthcare providers at the study sites engaged in diabetes care provision related to the study

Exclusion Criteria

  • Recipients of Care exclusion criteria:
  • People living with type 1 diabetes under 4 years of age.
  • People diagnosed with type 1 diabetes within the last 2 years.
  • People who have used a CGM in the last 6 months prior to enrollment.
  • People who anticipate that they would have access to a CGM through means outside this study during the duration of the study (15 months).
  • People living with type 2 diabetes.
  • Known pregnancy at time of enrolment.

Outcomes

Primary Outcomes

Not specified

Similar Trials